CytomX Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
Location
151 Oyster Point Blvd., Suite 400, South San Francisco, CA

Insiders trading volume in the past year

CytomX Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sean A. McCarthy CEO, Director $3.16M -$172K -5.15% Sep 26, 2025
Marcia Belvin SVP, Chief Scientific Officer $732K -$49K -6.28% Sep 26, 2025
Christopher Ogden Chief Financial Officer $608K -$38.5K -5.95% Sep 26, 2025
Jeffrey B. Landau Chief Business Officer $156K Aug 20, 2024
Alison L. Hannah Chief Medical Officer $85.5K Jul 19, 2022
Yu-Waye Chu Chief Medical Officer $81.3K -$2.41K -2.88% Sep 26, 2025
Amy C. Peterson EVP, Chief Development Officer $80.7K Mar 16, 2023
Lloyd Rowland General Counsel $72.2K -$6.11K -7.8% Mar 18, 2025
Carlos Campoy Chief Financial Officer $52.8K Mar 16, 2023
Zhen Su Director Jun 11, 2025
Alan Ashworth Director Jun 11, 2025
Matthew P. Young Director Jun 11, 2025
Elaine V. Jones Director Jun 11, 2025
Mani Mohindru Director Jun 11, 2025
Halley E. Gilbert Director Jun 11, 2025
Frederick W. Gluck Director Jun 15, 2022
James R. Meyers Director Jun 11, 2025
John A. Scarlett Director Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for CytomX Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.